James E Aikens1, Ann-Marie Rosland2, John D Piette3. 1. Department of Family Medicine, University of Michigan, Ann Arbor, MI, USA. Electronic address: aikensj@umich.edu. 2. Division of General Internal Medicine, University of Michigan, Ann Arbor, MI, USA; VA Ann Arbor Center for Clinical Management Research, Ann Arbor, MI, USA. 3. VA Ann Arbor Center for Clinical Management Research, Ann Arbor, MI, USA; Department of Health Behavior and Health Education, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
Abstract
OBJECTIVE: The objective of this observational open label trial was to characterize changes in diabetes self-management and psychological distress associated with a mobile health (mHealth) interactive voice response (IVR) self-management support program. METHODS: For 3-6 months, 301 patients with diabetes received weekly IVR calls assessing health status and self-care and providing tailored pre-recorded self-management support messages. Patients could participate together with an informal caregiver who received suggestions on self-management support, and patients' clinicians were notified automatically when patients reported significant problems. RESULTS: Patients completed 84% of weekly calls, providing 5682 patient-weeks of data. Thirty-nine percent participated with an informal caregiver. Outcome analyses adjusted for study design factors and sociodemographics indicated significant pre-post improvement in medication adherence, physical functioning, depressive symptoms, and diabetes-related distress (all p values <0.001). Analyses of self-management problems indicated that as the intervention proceeded, there were significant improvements in patients' IVR-reported frequency of weekly medication adherence, SMBG performance, checking feet, and frequency of abnormal self-monitored blood glucose readings (all p values <0.001). CONCLUSIONS: We conclude that the combined program of automated telemonitoring, clinician notification, and informal caregiver involvement was associated with consistent improvements in medication adherence, diabetes self-management behaviors, physical functioning, and psychological distress. A randomized controlled trial is needed to verify these encouraging findings.
OBJECTIVE: The objective of this observational open label trial was to characterize changes in diabetes self-management and psychological distress associated with a mobile health (mHealth) interactive voice response (IVR) self-management support program. METHODS: For 3-6 months, 301 patients with diabetes received weekly IVR calls assessing health status and self-care and providing tailored pre-recorded self-management support messages. Patients could participate together with an informal caregiver who received suggestions on self-management support, and patients' clinicians were notified automatically when patients reported significant problems. RESULTS:Patients completed 84% of weekly calls, providing 5682 patient-weeks of data. Thirty-nine percent participated with an informal caregiver. Outcome analyses adjusted for study design factors and sociodemographics indicated significant pre-post improvement in medication adherence, physical functioning, depressive symptoms, and diabetes-related distress (all p values <0.001). Analyses of self-management problems indicated that as the intervention proceeded, there were significant improvements in patients' IVR-reported frequency of weekly medication adherence, SMBG performance, checking feet, and frequency of abnormal self-monitored blood glucose readings (all p values <0.001). CONCLUSIONS: We conclude that the combined program of automated telemonitoring, clinician notification, and informal caregiver involvement was associated with consistent improvements in medication adherence, diabetes self-management behaviors, physical functioning, and psychological distress. A randomized controlled trial is needed to verify these encouraging findings.
Authors: Michael J Stirratt; Jacqueline Dunbar-Jacob; Heidi M Crane; Jane M Simoni; Susan Czajkowski; Marisa E Hilliard; James E Aikens; Christine M Hunter; Dawn I Velligan; Kristen Huntley; Gbenga Ogedegbe; Cynthia S Rand; Eleanor Schron; Wendy J Nilsen Journal: Transl Behav Med Date: 2015-07-09 Impact factor: 3.046
Authors: William H Polonsky; Lawrence Fisher; Jay Earles; R James Dudl; Joel Lees; Joseph Mullan; Richard A Jackson Journal: Diabetes Care Date: 2005-03 Impact factor: 19.112
Authors: Ann-Marie Rosland; Michele Heisler; Mary R Janevic; Cathleen M Connell; Kenneth M Langa; Eve A Kerr; John D Piette Journal: Fam Syst Health Date: 2013-06 Impact factor: 1.950
Authors: Robert M Anderson; Martha M Funnell; James E Aikens; Sarah L Krein; James T Fitzgerald; Robin Nwankwo; Cheryl L Tannas; Tricia S Tang Journal: Ther Patient Educ Date: 2009-06-01
Authors: Erin D Bouldin; Lynn Shaull; Elena M Andresen; Valerie J Edwards; Lisa C McGuire Journal: J Rural Health Date: 2017-09-23 Impact factor: 4.333
Authors: William H Polonsky; Jennifer E Layne; Christopher G Parkin; Coco M Kusiak; Nathan A Barleen; David P Miller; Howard Zisser; Ronald F Dixon Journal: Clin Diabetes Date: 2020-10
Authors: Margaret F Zupa; John D Piette; Shelley C Stoll; D Scott Obrosky; Monique Boudreaux-Kelly; Ada O Youk; Luc Overholt; Ranak Trivedi; Michele Heisler; Ann-Marie Rosland Journal: Am J Manag Care Date: 2021-10 Impact factor: 2.229